• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

HOFSETH BIOCARE ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING

HBCRegulatory press release2026-07-09 19:19

Reference is made to the stock exchange announcements by Hofseth BioCare ASA ("HBC" or the "Company") on 28 and 29 June 2026 regarding completion of delivery of Offer Shares in tranche 2 (the "T2 Offer Shares") where its subject to an extraordinary general meeting (the "EGM") resolving to inter alia, (i) issue the T2 Offer Shares in the Private Placement and (ii) amend the terms of the Company’s B-shares ("B-Shares Amendments").

The Board therefore calls for an EGM to be held at the offices of the Company at Keiser Wilhelms gate 24, Ålesund on 30 July 2026 at 11:00 hours CEST. The Company has already received voting undertakings from shareholders representing the necessary majority requirement to approve the T2 Offer Shares transaction and B-Shares Amendments at the EGM.

For further information, please contact:

Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 93632966
E-mail: investor@hofsethbiocare.no

Attachment

  • HBC EGM notice